Derong Wang

Title: Derong Wang: Innovator in Biomedicine

Introduction

Derong Wang is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of biomedicine, particularly in the development of vaccines and therapeutic agents.

Latest Patents

Wang holds a patent for "Mutants of respiratory syncytial virus fusion proteins." This invention relates to an improved mutant of a respiratory syncytial virus (RSV) fusion (F) protein. The mutant can form a trimeric structure without introducing a heterologous trimerization domain. Through various mutation designs, such as releasing internal electrostatic repulsion, deleting the furin cleavage site, truncating the C-terminal domain, and introducing interchain disulfide bonds, the protein is stabilized in the pre-fusion conformation and exhibits enhanced stability. This mutant is highly immunogenic when used as a vaccine or a vaccine component, inducing the production of a high level of neutralizing antibodies in immunized animals. It can be utilized in the preparation of a vaccine for the prevention or treatment of RSV infection and can also serve as a reagent for the detection of RSV.

Career Highlights

Wang is currently associated with Yikang Biotech (Suzhou) Co., Ltd., where he continues to advance his research in biomedicine. His work has garnered attention for its potential impact on public health.

Collaborations

Wang collaborates with notable colleagues, including Lei Chen and Yujiao Song, contributing to a dynamic research environment.

Conclusion

Derong Wang's innovative work in the field of biomedicine, particularly his advancements in RSV fusion proteins, showcases his commitment to improving health outcomes through scientific research. His contributions are paving the way for future developments in vaccine technology.